The pathological hallmarks are aggregation of amyloid in plaques and aggregation of tau in neurofibrillary tangles in the brain and biomarkers for amyloid and tau pathology are now used for the diagnosis of AD [1,2,3,4,5,6]. The gene discussed is MAPT; the disease is amyloidosis.